SynopsisThe global Spring Based Needle Free Injector market was valued at US$ 218 million in 2023 and is anticipated to reach US$ 549.7 million by 2030, witnessing a CAGR of 9.9% during the forecast period 2024-2030. North American market for Spring Based Needle.....
SynopsisFAM20B (FAM20B Glycosaminoglycan Xylosylkinase) is a Protein Coding gene. Diseases associated with FAM20B include Desbuquois Dysplasia and Gingival Fibromatosis. Gene Ontology (GO) annotations related to this gene include kinase activity and phosphotransferase.....
SynopsisThe global H2 Receptor Antagonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing.....
SynopsisThe global Orthodontic Retainer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Orthodontic Retainer is estimated to increase.....
SynopsisThe global Idiopathic Pulmonary Fibrosis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2.....
SynopsisThe global Ophthalmol Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a C.....
SynopsisThe global Chlorhexidine Citrate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Chlorhexidine Citrate is estimated to increa.....
SynopsisEXTL1 (Exostosin Like Glycosyltransferase 1) is a Protein Coding gene. Diseases associated with EXTL1 include Hereditary Multiple Exostoses and Exostosis. The global EXTL1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ .....
SynopsisThe global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a.....
SynopsisThe global Polyamide Biodegradable Plate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Polyamide biodegradable board is a biodegradable plastic mater.....